GlassScriptPhysician profile
Zachary T Young
NPI 1952503807
$3,035.78
in general payments reported to CMS, 2019-2025
30 companies · $78.36 in 2025
The $78.36 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $286 · 2021: $65.51 · 2022: $82.75 · 2023: $52.14 · 2025: $78.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $548.77 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $516.73 | 2019-2021 | |
| Genentech USA, INC. | $370.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $287.27 | 2019-2021 | |
| Grifols USA, LLC | $191.22 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $130.12 | 2019-2021 | |
| Insmed, INC. | $93.95 | 2019-2020 | |
| Intuitive Surgical, INC. | $82.75 | 2022 | |
| Sunovion Pharmaceuticals INC. | $82.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $81.49 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.46 | 2023-2025 | Lifevest |
| Jazz Pharmaceuticals INC. | $72.64 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $59.33 | 2019 | |
| United Therapeutics Corporation | $52.46 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.74 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $47.18 | 2019 | |
| Philips North America LLC | $40.36 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $34.60 | 2019-2020 | |
| Advanced Respiratory, INC | $27.66 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $22.67 | 2019 | |
| Array Biopharma INC | $22.64 | 2019 | |
| Inspire Medical Systems, INC. | $22.57 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $21.52 | 2019 | |
| Olympus America INC. | $17.07 | 2020 | |
| Shire North American Group INC | $16.56 | 2019 | |
| Resmed Corp | $16.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.60 | 2019 | |
| Incyte Corporation | $12.77 | 2020 | |
| Apria Healthcare LLC | $11.30 | 2021 | |
| Janssen Biotech, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.